Home Trials Genes Drugs 23andMe Graph Blog Contact

Home
Trials
Genes
Drugs
23andMe
Graph
Blog
Contact

Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

ClinicalTrials.gov
OpenTargets
ClinVar
PubChem

Results for “Decompensated Non-Alcoholic Steatohepatitis Cirrhosis”

3 trials

Filters

Phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Status

Recruiting

Active, Not Recruiting

Not Yet Recruiting

Completed

Enrolling by Invitation

Showing 3 of 3 results

Not applicableEnded earlyNCT03479125

What this trial is testing

Post-Treatment Follow-up Study for Liver Disease Subjects With or Without Cirrhosis After Receiving Emricasan or Placebo

Who this might be right for

Liver DiseasesLiver FibrosisLiver Cirrhosis+3 more

Conatus Pharmaceuticals Inc. 40

Testing effectiveness (Phase 2)UnknownNCT03205345

What this trial is testing

Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis

Who this might be right for

Decompensated Cirrhosis

Conatus Pharmaceuticals Inc. 210

Testing effectiveness (Phase 2)Ended earlyNCT03827200

What this trial is testing

A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis

Who this might be right for

CirrhosisPortal HypertensionAscites

Noorik Biopharmaceuticals AG 19

Filters

Phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Status

Recruiting

Active, Not Recruiting

Not Yet Recruiting

Completed

Enrolling by Invitation